As of 2024, the estimated number of cardiologists employed in the United States ranged from ** cardiologists to around ***** by state. New York registered the highest number of cardiologists, whereas North Dakota and West Virginia had the lowest.
As of January 2025, there were a total of 566,723 specialty physicians active in the United States. Of these, most were specialized in emergency medicine. Physician compensation Significant pay variations exist across specialties and regions, with orthopedic doctors and surgeons command the highest average annual salaries at 558,000 U.S. dollars. Meanwhile, the West North Central area offers the highest average physician compensation at 404,000 U.S. dollars annually. This region's higher pay likely stems from lower physician density in rural areas, creating less competition. Interestingly, doctors in Northeastern and Southwestern parts of the United States tend to earn less than their counterparts in other regions. Burnout among physicians Despite high salaries, U.S. physicians face high workload and stress in the workplace. Nearly half of surveyed doctors reported feeling burnout, with higher burnout rates among female doctors, younger physicians, and those in primary care compared to their counterparts. More effort to combat burnout is needed in the healthcare system. Increasing compensation was cited by physicians as the top measure to alleviate burnout, followed by adding support staff and offering more flexible schedules.
This dataset provides information on 3,564 in New Jersey, United States as of June, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
This statistic shows the total number of doctors of medicine in the United States from 1949 to 2015. In 1949, there were 201,277 doctors of medicine in the United States. Some 50 years later, the number was around four times as high. In 2015, the exact number of doctors of medicine was 1,085,783.
Comprehensive dataset of 410 Pediatric cardiologists in Illinois, United States as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.
As of May 2024, there were a total of 15,527 active specialty physicians in the U.S. state of Georgia. This included some 1,355 psychiatrists and 639 oncologists.
This dataset provides information on 40 in Kansas, United States as of May, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 1.51(USD Billion) |
MARKET SIZE 2024 | 1.56(USD Billion) |
MARKET SIZE 2032 | 2.1(USD Billion) |
SEGMENTS COVERED | Product Type ,Number of Leads ,Material ,Application ,End User ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Rising demand for home healthcare Technological advancements Increasing prevalence of cardiovascular diseases Government initiatives to promote healthcare Rapidly aging population |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Edan Instruments ,Royal Philips Healthcare ,Mindray Medical ,Fukuda Denshi ,GE Healthcare ,AliveCor ,Zoll Medical ,Contec Medical Systems ,Spacelabs Healthcare ,Welch Allyn ,BioTelemetry ,Meditronic ,Siemens Healthineers ,Schiller AG ,Nihon Kohden Corporation |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Growing demand for home healthcare Advancement in technology Increasing prevalence of cardiovascular diseases Rising geriatric population Expanding healthcare infrastructure |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.76% (2025 - 2032) |
This dataset provides information on 18 in Montana, United States as of May, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
Transradial Access Devices Market Size 2024-2028
The transradial access devices market size is forecast to increase by USD 803.3 million at a CAGR of 6.8% between 2023 and 2028.
Transradial access devices have gained significant traction in the market due to the increasing number of cardiovascular diseases (CVDs) and the subsequent rise in percutaneous coronary intervention (PCI) procedures. The advanced medical technologies used in these devices offer several advantages over traditional radial and femoral access methods, making them a preferred choice for hospitals and healthcare providers. The market is driven by government initiatives aimed at increasing awareness of CVDs and providing affordable treatment options. However, the lack of skilled interventional cardiologists poses a challenge to the widespread adoption of transradial access devices. This trend is expected to continue as the demand for minimally invasive procedures and improved patient outcomes increases.
What will be the Size of the Market During the Forecast Period?
Request Free Sample
Transradial access devices have emerged as a significant trend in advanced medical technologies for cardiovascular diseases. These devices enable interventions through the radial artery in the wrist instead of the traditional femoral approach in the groin. This shift towards transradial access is driven by the growing number of hospitalizations and diagnostic procedures for cardiovascular conditions. Cardiovascular diseases remain a leading cause of morbidity and mortality in the US. Hospitals and healthcare providers are increasingly adopting transradial access devices to improve patient comfort and reduce complications associated with traditional catheterization procedures.
Interventional cardiology procedures such as angioplasty and stent placement can now be performed using transradial access, leading to better patient outcomes. Diagnostic angiography and peripheral vascular interventions are other areas where transradial access devices have gained popularity. The minimally invasive nature of these procedures aligns well with the trend towards outpatient care and ambulatory care centers. Training programs for healthcare professionals are also being developed to increase the adoption and proficiency in using transradial access devices.
How is this market segmented and which is the largest segment?
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
Application
Drug administration
Fluid and nutrition administration
Diagnostics and testing
Blood transfusion
Geography
North America
US
Europe
Germany
UK
Asia
China
Japan
Rest of World (ROW)
By Application Insights
The drug administration segment is estimated to witness significant growth during the forecast period.
Transradial access devices have gained significant popularity among cardiovascular disease patients undergoing percutaneous coronary procedures in hospitals and healthcare facilities worldwide. The shift from the traditional transfemoral approach to the transradial approach has been driven by advancements in medical technologies and the increasing preference for minimally invasive procedures. However, the use of transradial access devices is not without challenges. Radial artery spasm (RAS), which can lead to procedural failures, is a common issue with the transradial approach. The reported incidence of RAS ranges from 5% to 30%. Predisposing factors for RAS include younger age, female gender, diabetes, smaller wrist circumference, and lower body weight.
However, to mitigate the risk of RAS, healthcare providers have turned to the administration of topical medications during the procedure. By addressing this challenge, the market is poised for continued growth in the markets.
Get a glance at the market report of share of various segments Request Free Sample
The drug administration segment was valued at USD 689.90 million in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 47% to the growth of the global market during the forecast period.
Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
In North America, the market is experiencing notable expansion during the forecast period. In 2023, North America held the largest market share in The market. The US is the primary revenue generator for this market in the region, attributed to the substantial prevalence of coronary artery disease (CAD) and heightened awareness of advanced tra
According to a ranking of the best hospitals in the U.S., the best hospital for adult cardiology, heart, and vascular surgery is the Cleveland Clinic in Ohio, which had a score of 100 out of 100, as of 2024. This statistic shows the top 10 hospitals for adult cardiology, heart, and vascular surgery in the United States based on the score given by U.S. News and World Report's annual hospital ranking.
Comprehensive dataset of 137 Pediatric cardiologists in Tennessee, United States as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.
https://dataintelo.com/privacy-and-policyhttps://dataintelo.com/privacy-and-policy
The global fluorodeoxyglucose (FDG) market size was valued at approximately USD 1.5 billion in 2023 and is projected to reach USD 2.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. The growth of the FDG market is primarily driven by the increasing incidence of cancer and the rising demand for advanced diagnostic techniques in various medical fields.
One of the major growth factors in the FDG market is the surge in cancer prevalence worldwide. The use of FDG in positron emission tomography (PET) scans is considered a gold standard for detecting and monitoring cancer. The increasing number of cancer cases is pushing healthcare providers to adopt more precise diagnostic tools like FDG-PET, thereby boosting the market. Additionally, advancements in PET scan technology and the integration of FDG in various imaging techniques are further propelling the market's growth. The growing awareness among patients and healthcare professionals about early cancer detection is also playing a significant role in the market's expansion.
Another crucial growth factor is the increasing adoption of FDG in cardiology and neurology. FDG is integral for diagnosing and monitoring various cardiac conditions and neurodegenerative diseases. In cardiology, FDG-PET scans are used to assess myocardial viability and detect coronary artery disease. In neurology, FDG helps in the diagnosis of conditions like Alzheimer's disease and epilepsy. The rising incidence of cardiovascular and neurological disorders is contributing to the growing demand for FDG, further enhancing market growth. The ongoing research and development activities to explore new applications of FDG in these medical fields are also supporting market expansion.
The expanding healthcare infrastructure and increasing government initiatives to improve diagnostic facilities in emerging economies are also driving the FDG market. Countries in the Asia Pacific and Latin American regions are witnessing significant improvements in their healthcare systems, which is boosting the adoption of advanced diagnostic tools like FDG-PET. Government policies aimed at enhancing cancer care and early detection are further stimulating market growth. Additionally, the collaboration between public and private sectors to develop state-of-the-art medical facilities is expected to create lucrative opportunities for market players.
Regionally, North America holds the largest share of the FDG market, owing to the high prevalence of cancer and other chronic diseases, coupled with advanced healthcare infrastructure. Europe is also a significant market, driven by the rising demand for early diagnostic tools and the presence of major market players. The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, attributed to the improving healthcare infrastructure and increasing government initiatives. Latin America and the Middle East & Africa regions are also expected to exhibit substantial growth, driven by the expanding healthcare sector and rising awareness about advanced diagnostic techniques.
The application segment of the FDG market is broadly categorized into oncology, cardiology, neurology, and others. In oncology, FDG-PET scans are extensively used for the detection, staging, and monitoring of various types of cancers. The increasing prevalence of cancer worldwide is driving the demand for FDG in oncology applications. FDG-PET provides high sensitivity and specificity, making it an indispensable tool for oncologists. Moreover, the integration of FDG-PET with other imaging modalities like CT and MRI is enhancing the diagnostic accuracy, further boosting the market growth in the oncology segment.
In cardiology, FDG is used primarily for the assessment of myocardial viability and the detection of coronary artery diseases. The rising incidence of cardiovascular diseases globally is driving the demand for advanced diagnostic tools like FDG-PET. FDG-PET helps in identifying viable myocardial tissues, assisting cardiologists in making informed decisions regarding revascularization procedures. The ongoing research to explore new applications of FDG in cardiology, such as the detection of inflammation in atherosclerotic plaques, is expected to create new growth opportunities in this segment.
Neurology is another significant application area for FDG, where it is used for diagnosing and monitoring neurodegenerative diseases like Alzheimer's disease,
This dataset provides information on 57 in Iowa, United States as of May, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
This dataset provides information on 58 in Arkansas, United States as of May, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
This dataset provides information on 132 in South Carolina, United States as of May, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
This dataset provides information on 8,124 in United States as of June, 2025. It includes details such as email addresses (where publicly available), phone numbers (where publicly available), and geocoded addresses. Explore market trends, identify potential business partners, and gain valuable insights into the industry. Download a complimentary sample of 10 records to see what's included.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
As of 2024, the estimated number of cardiologists employed in the United States ranged from ** cardiologists to around ***** by state. New York registered the highest number of cardiologists, whereas North Dakota and West Virginia had the lowest.